IL320766A - Methods for producing fused polypeptides - Google Patents

Methods for producing fused polypeptides

Info

Publication number
IL320766A
IL320766A IL320766A IL32076625A IL320766A IL 320766 A IL320766 A IL 320766A IL 320766 A IL320766 A IL 320766A IL 32076625 A IL32076625 A IL 32076625A IL 320766 A IL320766 A IL 320766A
Authority
IL
Israel
Prior art keywords
methods
fusion polypeptides
making fusion
making
polypeptides
Prior art date
Application number
IL320766A
Other languages
English (en)
Hebrew (he)
Original Assignee
Ankyra Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ankyra Therapeutics Inc filed Critical Ankyra Therapeutics Inc
Publication of IL320766A publication Critical patent/IL320766A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5434—IL-12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/11—Protein-serine/threonine kinases (2.7.11)
    • C12Y207/11001—Non-specific serine/threonine protein kinase (2.7.11.1), i.e. casein kinase or checkpoint kinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL320766A 2022-11-09 2025-05-07 Methods for producing fused polypeptides IL320766A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263424047P 2022-11-09 2022-11-09
PCT/US2023/037011 WO2024102400A2 (en) 2022-11-09 2023-11-08 Methods of making fusion polypeptides

Publications (1)

Publication Number Publication Date
IL320766A true IL320766A (en) 2025-07-01

Family

ID=89164434

Family Applications (1)

Application Number Title Priority Date Filing Date
IL320766A IL320766A (en) 2022-11-09 2025-05-07 Methods for producing fused polypeptides

Country Status (8)

Country Link
EP (1) EP4615976A2 (de)
JP (1) JP2025540624A (de)
KR (1) KR20250122543A (de)
CN (1) CN120500541A (de)
AU (1) AU2023376942A1 (de)
IL (1) IL320766A (de)
MX (1) MX2025005424A (de)
WO (1) WO2024102400A2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022538974A (ja) 2019-06-26 2022-09-07 マサチューセッツ インスチテュート オブ テクノロジー 免疫調節融合タンパク質－金属水酸化物錯体およびその方法
US12454695B2 (en) * 2021-05-05 2025-10-28 Ankyra Therapeutics, Inc. Fusion polypeptides comprising interleukin 12 and a metal-hydroxide binding polypeptide

Also Published As

Publication number Publication date
MX2025005424A (es) 2025-07-01
WO2024102400A2 (en) 2024-05-16
CN120500541A (zh) 2025-08-15
JP2025540624A (ja) 2025-12-16
AU2023376942A1 (en) 2025-05-15
KR20250122543A (ko) 2025-08-13
EP4615976A2 (de) 2025-09-17
WO2024102400A3 (en) 2024-07-18

Similar Documents

Publication Publication Date Title
IL286745A (en) Continuous production of recombinant proteins
IL317645A (en) Methods for preparing tolbrutinib
IL308240A (en) Conjugated polypeptides
IL279782B2 (en) Methods for producing recombinant proteins
GB202113559D0 (en) Fusion polypeptide
GB201902908D0 (en) Method of using a blockchain
IL316697A (en) Novel CD200 fusion proteins
IL320770A (en) Methods for producing fused polypeptides
IL314282A (en) Chimeric polypeptides
EP4294422A4 (de) Anti-pathogen-interleukin-tgf-beta-rezeptor-fusionspolypeptide
HK40128690A (en) Methods of making fusion polypeptides
CA3273017A1 (en) Methods of making fusion polypeptides
HK40128691A (zh) 一种制备融合多肽的方法
GB202217084D0 (en) Therapeutic fusion proteins
GB201913804D0 (en) Fusion polypeptides
GB202315671D0 (en) Polypeptides
GB202105044D0 (en) Fusion protein
GB202219576D0 (en) Polypeptides
IL317593A (en) Follistatin-FC fusion proteins
GB202218084D0 (en) Fusion proteins
GB202402535D0 (en) Fusion proteins
CA3292598A1 (en) Antagonist fusion polypeptides
AU2024277146A1 (en) Antagonist fusion polypeptides
IL317203A (en) CD38-binding fusion protein dosage
IL318371A (en) Inhibitors of KLK5 fusion proteins